ALFA Finder
India's fastest NSE & BSE filing alerts on Telegram, filtered to the stocks you hold
Telegram alerts
alfafinder.com →
ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
5 announcements with these filters
Q2 FY27: standalone income up 32% YoY to ₹305.4 Cr on bromine pricing; consolidated PAT only up 8%. H1 consolidated EBITDA down 5.2%; SOP guidance cut to 3.5–4k t, with fuel and PVC risks.
Q2FY27 consolidated income Rs301.6 Cr (+25.9% YoY), PAT Rs31.3 Cr (+7.9%). Bromine revenue +76%, bromine derivatives +81%. Strategy centres on SiC semiconductor fab and zinc-bromide batteries.
Archean Chemical reported Q1 FY27 consolidated revenue of INR 3,328.1M, up 10.7% YoY. Standalone margins improved to 25.3%, with bromine derivatives business turning EBITDA positive for the first time.
Archean reported Q1FY27 consolidated revenue of ₹3,328 Mn, up 11% YoY. Strategy focuses on bromine derivatives, semiconductors via SiCSem, and energy storage through Offgrid Energy Labs.
Q4FY26 revenue at ₹306.3cr (consolidated). Management reports headwind from US-Iran conflict and Kutch logistics issues, but remains bullish on core salt and bromine expansion.